Position in DTIL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,403,265
+$2,157,041 QoQ
Shares Held
305,759
+583.0% QoQ
Ownership
1.11%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 95 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DTIL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ACADIAN ASSET MANAGEMENT LLC holds $731,256,203 across 167 Biotechnology names. DTIL ranks #45 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
1,664,999 | $188,744,286 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,440 | $98,170,137 | |
| 3 | IMCR |
Immunocore Holdings plc
|
1,209,894 | $38,414,134 | |
| 4 | RIGL |
Rigel Pharmaceuticals Inc
|
591,686 | $23,146,756 | |
| 5 | EXEL |
Exelixis, Inc.
|
421,444 | $22,930,768 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
42,122 | $20,923,261 | |
| 7 | TBPH |
Theravance Biopharma, Inc.
|
1,174,910 | $19,973,470 | |
| 8 | PRTA |
Prothena Corp Public Ltd Co
|
2,010,645 | $19,684,214 |
All Filings in DTIL
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,403,265 | 305,759 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $246,224 | 44,768 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $234,270 | 56,315 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $658,861 | 119,359 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $948,935 | 225,937 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $1,185,917 | 248,620 | Shares | Defined | 2025-05-21 | |
| 2024-12-31 | $947,242 | 248,620 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $1,345,612 | 150,180 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,077,821 | 110,773 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $1,549,528 | 114,272 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,220,528 | 3,343,914 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,073,550 | 3,148,243 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,528,460 | 2,905,818 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $2,190,986 | 2,905,818 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $3,198,119 | 2,687,495 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,980,218 | 2,292,476 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,589,193 | 2,243,246 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $3,101,387 | 1,006,944 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $2,867,758 | 387,535 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $1,656,093 | 143,509 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $517,927 | 41,368 | Shares | Defined | 2021-08-11 | |
| 2020-03-31 | $140,058 | 23,227 | Shares | Defined | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||